Neuprozyme Therapeutics ApS
CVR 40010106 · Private limited company (ApS) · Active · Low risk
Neuprozyme Therapeutics ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry fremstilling af andre organiske basiskemikalier. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 8 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 82k and a net result of DKK -26k. CEO: John Pedersen.
Bankruptcy risk for Neuprozyme Therapeutics ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40010106
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Agern Alle 3
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Fremstilling af andre organiske basiskemikalier (201400)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 50k
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 75.5% |
| Current ratio | 408% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 58 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -27k | DKK -27k | DKK -1,074 |
| Net profit | DKK -26k | DKK -25k | DKK -21k |
| Equity | DKK 82k | DKK 108k | DKK 133k |
| Total assets | DKK 109k | DKK 133k | DKK 158k |
| Cash | DKK 100k | DKK 126k | – |
| Short-term debt | DKK 27k | DKK 26k | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 130 | ||
| 1 Jul 2023 – 30 Jun 2024 | 162 | ||
| 1 Jul 2022 – 30 Jun 2023 | 117 | ||
| 1 Jul 2021 – 30 Jun 2022 | 175 | ||
| 1 Jul 2020 – 30 Jun 2021 | 168 | ||
| 1 Jul 2019 – 30 Jun 2020 | 164 | ||
| 1 Jul 2018 – 30 Jun 2019 | 149 | ||
| 1 Jul 2017 – 30 Jun 2018 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | John Pedersen | Current | |
| Board | Lone Ballegaard Pedersen | Current | |
| Board | John Pedersen | Current | |
| Owner (100%) | LJP HOLDING ApS | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | Current | |
| Auditor | ALBJERG STATSAUTORISERET REVISIONSAKTIESELSKAB |
The CEOs' other companies
John Pedersen – 5 other companies
- Famalii Sport & Byliv ApS Active
- LJP HOLDING ApS Active
- PROZYMEX ApS Fusioneret
- Prozymex 2017 ApS Active
- UNIZYME LABORATORIES ApS Active
Address history (0 moves)
| Agern Alle 3, 2970 Hørsholm |
Other companies at the same address
- AFVIKLINGSSELSKABET AF 16/12 1997 ApS Bankrupt
- Flyttedagen.dk ApS Bankrupt
- GLYCANOVA A/S Bankrupt
- Immumap Services ApS Bankrupt
- Jon Kølle Christensen Holding IVS Bankrupt
- LOGVIEW A/S Bankrupt
- LOUDSOFT ApS Bankrupt
- MARIDAN A/S Bankrupt
- MARITIME HOLDING ApS Bankrupt
- Medodan ApS Bankrupt
- PARETA SOCIAL ApS Bankrupt
- SCI-TECH INTERNATIONAL INC. ApS Bankrupt
- SEFF SYSTEMS A/S Bankrupt
- SOUNDFACTS ApS Bankrupt
- TRYGCONSULT A/S Bankrupt
- Wilta Shipping IVS Bankrupt
- 3P Third Party Holding ApS Fusioneret
- AQUATRONIC A/S Opløst
- ARCTIC ApS Compulsorily dissolved
- ARMORLOGIC ApS Opløst
- Alontia A/S Active
- BJERRUM OG KROGH ApS Compulsorily dissolved
- CAPITAL+ MANAGEMENT B-AKTIER ApS Opløst
- CATALYST GROUP ApS Fusioneret
- CONTICA HOLDING ApS Active
Similar companies in Rudersdal
- Hyphox ApS Holte
- Prozymex 2017 ApS Hørsholm
- UNIZYME LABORATORIES ApS Hørsholm
- PROZYMEX ApS Hørsholm
Questions and answers about Neuprozyme Therapeutics ApS
Has Neuprozyme Therapeutics ApS gone bankrupt?
No, Neuprozyme Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Neuprozyme Therapeutics ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Neuprozyme Therapeutics ApS?
John Pedersen is the CEO of Neuprozyme Therapeutics ApS.
Who is the auditor of Neuprozyme Therapeutics ApS?
Neuprozyme Therapeutics ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was Neuprozyme Therapeutics ApS founded?
Neuprozyme Therapeutics ApS was founded on 19 September 2018.
What is the equity of Neuprozyme Therapeutics ApS?
Equity was DKK 82k according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.